Replies to post #6338 on Helix Technologies Inc. (fka HLIX)

[NobleRoman]

Your Predictions Exceeded

Wow. They did it! They squeaked out positive cash flow from operations alone. First time ever. Whew! I love that. I want to know what it was for just this quarter though. I don't see that. That has to better.

They had an increase in sales across all sectors, again. Not level as you imagined. This is good. If they can remain positive from operations alone, which seems much more probable without a security that's labor intensive, they may be more in alignment with my expectations.

That guard is was good too. That's going to be a big hit in sales, but hopefully expands our sails. They dramatically reduced their G&A too. I'm just barely glancing as I have to get back to work, but that's good on the surface. Have $2M in cash. And that's before the sale of Helix Security.

I'm only worried about dilution at this point. Thank you, Zac and team! They can be self-sustaining now, without the need of going to the market if all things remain in motion and the law of inertia holds up without some outside force acting upon it. Unless they want to do anotheer power grab. But I say let's coast a bit. I think the ball is in their court now for financing. I want to see all this crap refinanced at better terms.

[NobleRoman]

Amercanex Integration.

You said, " Mgmt has not spoken about the progress of next-gen biotrack, americanex or analytics"

I found this excerpt (some sections removed) to be highly interesting.

We have largely completed the financial and operational integrations of the previous 24 months, namely the acquisitions of BioTrackTHC, Engeni, Tan Security and Amercanex...

... Engeni has also become the Company’s organic offshore software development platform, and has delivered the second generation of the BioTrackTHC software...

...The Company has integrated Amercanex’s technology with BioTrackTHC’s software platforms. Integration of the previously announced acquisitions has already yielded the operational and financial results that the management team sought, evidenced by strongly improved cash flows from operations, growing market share, and a greatly accelerated software development time with increased market responsiveness.

These integrations still have room to yield more financial and operational leverage, which will be welcome in the unprecedented operating environment that now confronts the industry. Further, the turnaround of the BioTrackTHC unit is well advanced, with strategic restructuring in operations and personnel nearly complete, having been initiated in 2019. The transition of BioTrackTHC from an operation with negative $800,000 of Adjusted EBITDA in 2018 (while still better than competitors) into an operation that generated nearly $800,000 in Adjusted EBITDA in Q1 2020 and Q2 2020 is a transformational success.

Fascinating!

Of course, Tan was part of Helix Security and was sold. I like this company. I just don't like that conversion loss in the statement of cash flows. I don't like this price for conversions. But at the same time, it gave me a 40,000 share position at average of cost of .29.

As for your cannalytics, which I'm curious about too, it also says this in there:

Lastly, the Company generates monthly recurring revenues from Cannalytics, its business intelligence and data tool for commercial customers. Revenue is recognized monthly.

There is nothing else in there about it. I don't know how to break that out. That's a good question to add right there!

I'm going to have to move that question up to the top. If they go in order of priority, I want that to be addressed. Form 4's at the bottom. Sorry, no offense.